Welfare of Animals in Cosmetics Testing — Global Regulatory Patchwork

Cosmetics animal testing is banned in many countries but continues globally due to inconsistent regulations, creating a complex welfare landscape for international brands.

Key Facts

The EU banned cosmetics animal testing in 2013 and the sale of products tested on animals anywhere
China required animal testing for imported cosmetics until 2021 — regulatory reform has now opened alternatives
Brazil, the UK, and many other countries have followed the EU in banning cosmetics animal testing
The US has not nationally banned cosmetics animal testing but major brands have largely eliminated it voluntarily
Cruelty Free International Leaping Bunny certification is the most widely recognised third-party verification
Some cosmetic ingredients are also used in pharmaceuticals — these ingredients may still require animal safety data
In vitro methods, computer modelling, and human tissue tests can replace most cosmetics animal tests

Welfare Considerations

Cosmetics testing welfare has seen more regulatory and industry progress than almost any other sector of animal research. Consumer-driven demand for cruelty-free products, combined with the availability of replacement technologies, has largely eliminated animal testing from major cosmetics brands operating in the EU, UK, and similar markets. The remaining challenge is global consistency: brands selling in markets with testing requirements face a choice between market access and cruelty-free status. China's regulatory reform is the most significant recent development — opening the world's largest cosmetics market to genuinely cruelty-free products. Consumer purchasing power remains the most effective driver of further change.

What You Can Do

Choose Leaping Bunny or Cruelty Free International certified cosmetics
Avoid brands that sell in markets requiring animal testing without committing to alternatives
Support organisations campaigning for global cosmetics animal testing bans
Engage with cosmetics companies about their regulatory strategy in markets with testing requirements
Advocate for governments to accelerate acceptance of validated replacement testing methods